Diversified Healthcare Trust (DHC) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

DHC Stock Forecast

Diversified Healthcare Trust stock forecast is as follows: an average price target of $5.00 (represents a 116.45% upside from DHC’s last price of $2.31) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.

DHC Price Target

The average price target for Diversified Healthcare Trust (DHC) is $5.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $5.00 to $5.00. This represents a potential 116.45% upside from DHC's last price of $2.31.

DHC Analyst Ratings

Buy

According to 2 Wall Street analysts, Diversified Healthcare Trust's rating consensus is 'Buy'. The analyst rating breakdown for DHC stock is 0 'Strong Buy' (0.00%), 1 'Buy' (50.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 1 'Strong Sell' (50.00%).

Diversified Healthcare Trust Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Nov 06, 2024	Bryan Maher	B.Riley Financial	$5.00	$2.85	75.13%	116.45%
Aug 05, 2024	Bryan Maher	B.Riley Financial	$6.00	$3.13	91.39%	159.74%

The latest Diversified Healthcare Trust stock forecast, released on Nov 06, 2024 by Bryan Maher from B.Riley Financial, set a price target of $5.00, which represents a 75.13% increase from the stock price at the time of the forecast ($2.85), and a 116.45% increase from DHC last price ($2.31).

Diversified Healthcare Trust Price Target by Period

	1M	3M	12M
# Anlaysts	-	1	2
Avg Price Target	-	$5.00	$5.50
Last Closing Price	$2.31	$2.31	$2.31
Upside/Downside	-100.00%	116.45%	138.10%

In the current month, the average price target of Diversified Healthcare Trust stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Diversified Healthcare Trust's last price of $2.31. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Oct 14, 2024	RBC Capital	Underperform	Underperform	Hold
Aug 05, 2024	B. Riley	Buy	Buy	Hold
Apr 26, 2022	Zacks Investment Research		Strong Sell	Downgrade

Diversified Healthcare Trust's last stock rating was published by RBC Capital on Oct 14, 2024. The company gave DHC a "Underperform" rating, the same as its previous rate.

Diversified Healthcare Trust Financial Forecast

Diversified Healthcare Trust Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	$1.51B	$356.52M	$346.22M	$346.03M	$336.88M	$322.92M	$313.03M	$310.73M	$336.73M	$337.42M	$346.34M	$362.72M	$384.91M	$394.34M	$410.31M	$442.47M	$256.04M	$255.83M
Avg Forecast	$456.80M	$453.50M	$447.00M	$446.70M	$397.96M	$395.02M	$385.79M	$374.17M	$370.97M	$380.17M	$372.13M	$370.65M	$360.99M	$359.78M	$353.15M	$341.33M	$330.40M	$320.79M	$319.10M	$319.84M	$336.01M	$348.61M	$365.93M	$359.18M	$388.92M	$397.14M	$419.43M	$436.06M	$250.97M	$255.23M
High Forecast	$481.62M	$478.14M	$471.29M	$470.97M	$419.58M	$416.48M	$406.75M	$394.50M	$391.13M	$381.67M	$372.13M	$370.65M	$380.61M	$379.33M	$372.34M	$359.87M	$340.88M	$320.79M	$319.10M	$319.84M	$336.01M	$348.61M	$365.93M	$359.18M	$388.92M	$397.14M	$419.43M	$436.06M	$250.97M	$255.23M
Low Forecast	$431.98M	$428.86M	$422.71M	$422.43M	$376.34M	$373.56M	$364.83M	$353.84M	$350.81M	$378.67M	$372.13M	$370.65M	$341.38M	$340.24M	$333.96M	$322.78M	$319.90M	$320.79M	$319.10M	$319.84M	$336.01M	$348.61M	$365.93M	$359.18M	$388.92M	$397.14M	$419.43M	$436.06M	$250.97M	$255.23M
# Analysts	1	1	1	1	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5	9	6	4	4
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	4.19%	0.99%	0.98%	1.01%	1.02%	1.01%	0.98%	0.97%	1.00%	0.97%	0.95%	1.01%	0.99%	0.99%	0.98%	1.01%	1.02%	1.00%

Diversified Healthcare Trust's average Quarter revenue forecast for Mar 24 based on 1 analysts is $370.65M, with a low forecast of $370.65M, and a high forecast of $370.65M. DHC's average Quarter revenue forecast represents a -75.51% decrease compared to the company's last Quarter revenue of $1.51B (Dec 23).

Diversified Healthcare Trust EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5	9	6	4	4
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	$1.19B	$-46.49M	$-51.78M	$58.27M	$55.12M	$31.79M	$42.08M	$35.21M	$503.46M	$42.60M	$99.67M	$57.11M	$105.58M	$16.92M	$86.02M	$117.50M	$59.69M	$86.81M
Avg Forecast	$138.30M	$137.31M	$135.34M	$135.25M	$120.49M	$119.60M	$116.81M	$113.29M	$112.32M	$115.10M	$112.67M	$112.22M	$109.30M	$108.93M	$106.92M	$103.34M	$100.23M	$101.96M	$101.42M	$101.65M	$106.80M	$110.80M	$116.30M	$44.70M	$123.61M	$126.22M	$133.31M	$264.37M	$79.77M	$81.12M
High Forecast	$145.82M	$144.77M	$142.69M	$142.60M	$127.04M	$126.10M	$123.15M	$119.44M	$118.42M	$115.56M	$112.67M	$112.22M	$115.24M	$114.85M	$112.73M	$108.96M	$103.41M	$101.96M	$101.42M	$101.65M	$106.80M	$110.80M	$116.30M	$53.63M	$123.61M	$126.22M	$133.31M	$317.25M	$79.77M	$81.12M
Low Forecast	$130.79M	$129.85M	$127.98M	$127.90M	$113.94M	$113.10M	$110.46M	$107.13M	$106.22M	$114.65M	$112.67M	$112.22M	$103.36M	$103.01M	$101.11M	$97.73M	$97.04M	$101.96M	$101.42M	$101.65M	$106.80M	$110.80M	$116.30M	$35.76M	$123.61M	$126.22M	$133.31M	$211.50M	$79.77M	$81.12M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	10.93%	-0.43%	-0.48%	0.56%	0.55%	0.31%	0.41%	0.35%	4.71%	0.38%	0.86%	1.28%	0.85%	0.13%	0.65%	0.44%	0.75%	1.07%

1 analysts predict DHC's average Quarter EBITDA for Mar 24 to be $112.22M, with a high of $112.22M and a low of $112.22M. This is -90.60% lower than Diversified Healthcare Trust's previous annual EBITDA (Dec 23) of $1.19B.

Diversified Healthcare Trust Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5	9	6	4	4
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	$-102.56M	$-65.78M	$-72.57M	$-52.01M	$-62.69M	$-83.62M	$-112.59M	$240.42M	$366.76M	$-89.34M	$-34.22M	$-67.50M	$-16.23M	$-106.89M	$-26.07M	$9.73M	$-51.70M	$-29.39M
Avg Forecast	-	-	-	-	$-52.73M	$-52.73M	$-55.12M	$-59.92M	$-69.50M	$-62.31M	$-67.11M	$1.17B	$-59.92M	$-50.33M	$-52.73M	$1.26B	$316.84M	$-59.83M	$-69.40M	$1.34B	$-57.44M	$-55.04M	$-58.24M	$-52.83M	$-55.04M	$-34.10M	$-35.90M	$21.90M	$6.38M	$3.87M
High Forecast	-	-	-	-	$-49.00M	$-49.00M	$-51.23M	$-55.68M	$-64.60M	$-57.91M	$-62.37M	$1.41B	$-55.68M	$-46.78M	$-49.00M	$1.51B	$380.21M	$-59.83M	$-69.40M	$1.61B	$-57.44M	$-55.04M	$-58.24M	$-42.26M	$-55.04M	$-34.10M	$-35.90M	$26.28M	$6.38M	$3.87M
Low Forecast	-	-	-	-	$-56.45M	$-56.45M	$-59.02M	$-64.15M	$-74.41M	$-66.71M	$-71.85M	$939.52M	$-64.15M	$-53.88M	$-56.45M	$1.00B	$253.47M	$-59.83M	$-69.40M	$1.07B	$-57.44M	$-55.04M	$-58.24M	$-63.40M	$-55.04M	$-34.10M	$-35.90M	$17.52M	$6.38M	$3.87M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.71%	1.31%	1.38%	-0.04%	-0.20%	1.40%	1.62%	0.18%	-6.39%	1.62%	0.59%	1.28%	0.29%	3.13%	0.73%	0.44%	-8.10%	-7.59%

Diversified Healthcare Trust's average Quarter net income forecast for Jun 22 is $-69.40M, with a range of $-69.40M to $-69.40M. DHC's average Quarter net income forecast represents a -128.87% decrease compared to the company's last Quarter net income of $240.42M (Mar 22).

Diversified Healthcare Trust SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5	9	6	4	4
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	$6.95M	$7.28M	$5.87M	$5.76M	$6.18M	$7.21M	$7.29M	$8.55M	$8.87M	$9.13M	$7.54M	$7.46M	$6.99M	$7.31M	$77.26M	$78.24M	$82.97M
Avg Forecast	$10.79M	$10.71M	$10.56M	$10.55M	$9.40M	$9.33M	$9.11M	$8.84M	$8.76M	$8.98M	$8.79M	$35.59M	$8.53M	$8.50M	$8.34M	$38.06M	$7.41M	$7.04M	$7.01M	$40.70M	$7.38M	$7.65M	$8.03M	$5.90M	$8.54M	$8.72M	$9.21M	$173.84M	$5.51M	$5.60M
High Forecast	$11.38M	$11.29M	$11.13M	$11.13M	$9.91M	$9.84M	$9.61M	$9.32M	$9.24M	$9.02M	$8.79M	$42.70M	$8.99M	$8.96M	$8.80M	$45.67M	$8.89M	$7.04M	$7.01M	$48.85M	$7.38M	$7.65M	$8.03M	$7.08M	$8.54M	$8.72M	$9.21M	$208.61M	$5.51M	$5.60M
Low Forecast	$10.20M	$10.13M	$9.99M	$9.98M	$8.89M	$8.82M	$8.62M	$8.36M	$8.29M	$8.94M	$8.79M	$28.47M	$8.06M	$8.04M	$7.89M	$30.45M	$5.93M	$7.04M	$7.01M	$32.56M	$7.38M	$7.65M	$8.03M	$4.72M	$8.54M	$8.72M	$9.21M	$139.07M	$5.51M	$5.60M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.82%	0.87%	0.15%	0.78%	0.88%	1.03%	0.18%	1.16%	1.16%	1.14%	1.28%	0.87%	0.80%	0.79%	0.44%	14.20%	14.81%

Diversified Healthcare Trust's average Quarter SG&A projection for Dec 23 is $8.53M, based on 1 Wall Street analysts, with a range of $8.06M to $8.99M. The forecast indicates a 22.63% rise compared to DHC last annual SG&A of $6.95M (Sep 23).

Diversified Healthcare Trust EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	2	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	5	9	6	4	4
EPS	-	-	-	-	-	-	-	-	-	-	-	-	$-0.43	$-0.28	$-0.30	$-0.22	$-0.26	$-0.35	$-0.47	$1.01	$1.54	$-0.38	$-0.14	$-0.28	$-0.07	$-0.45	$-0.11	$0.04	$-0.22	$-0.12
Avg Forecast	-	-	-	-	$-0.22	$-0.22	$-0.23	$-0.25	$-0.29	$-0.26	$-0.28	$-0.28	$-0.25	$-0.21	$-0.22	$-0.23	$-0.28	$-0.25	$-0.29	$-0.26	$-0.24	$-0.23	$-0.24	$-0.25	$-0.23	$-0.14	$-0.15	$-0.14	$0.03	$0.02
High Forecast	-	-	-	-	$-0.20	$-0.20	$-0.21	$-0.23	$-0.27	$-0.24	$-0.26	$-0.26	$-0.23	$-0.20	$-0.20	$-0.21	$-0.27	$-0.25	$-0.29	$-0.26	$-0.24	$-0.23	$-0.24	$-0.25	$-0.23	$-0.14	$-0.15	$-0.14	$0.03	$0.02
Low Forecast	-	-	-	-	$-0.24	$-0.24	$-0.25	$-0.27	$-0.31	$-0.28	$-0.30	$-0.30	$-0.27	$-0.22	$-0.24	$-0.25	$-0.29	$-0.25	$-0.29	$-0.26	$-0.24	$-0.23	$-0.24	$-0.25	$-0.23	$-0.14	$-0.15	$-0.14	$0.03	$0.02
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.72%	1.33%	1.36%	0.96%	0.93%	1.40%	1.62%	-3.88%	-6.42%	1.65%	0.58%	1.14%	0.30%	3.16%	0.73%	-0.28%	-8.25%	-7.42%

According to 1 Wall Street analysts, Diversified Healthcare Trust's projected average Quarter EPS for Jun 22 is $-0.29, with a low estimate of $-0.29 and a high estimate of $-0.29. This represents a -128.71% decrease compared to DHC previous annual EPS of $1.01 (Mar 22).

Diversified Healthcare Trust Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
DHC	Diversified Healthcare Trust	$2.31	$5.00	116.45%	Buy
GMRE	Global Medical REIT	$7.83	$11.75	50.06%	Buy
NHI	National Health Investors	$67.36	$85.00	26.19%	Hold
DOC	Healthpeak Properties	$20.21	$24.75	22.46%	Buy
OHI	Omega Healthcare Investors	$36.17	$43.33	19.80%	Buy
SBRA	Sabra Health Care REIT	$16.58	$19.00	14.60%	Hold
VTR	Ventas	$59.60	$65.75	10.32%	Buy
HR	Healthcare Realty Trust	$16.68	$17.00	1.92%	Hold
CTRE	CareTrust REIT	$26.21	$25.50	-2.71%	Buy

DHC Forecast FAQ

Is Diversified Healthcare Trust a good buy?

Yes, according to 2 Wall Street analysts, Diversified Healthcare Trust (DHC) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 1 'Buy' recommendations, accounting for 50.00% of DHC's total ratings.

What is DHC's price target?

Diversified Healthcare Trust (DHC) average price target is $5 with a range of $5 to $5, implying a 116.45% from its last price of $2.31. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Diversified Healthcare Trust stock go up soon?

According to Wall Street analysts' prediction for DHC stock, the company can go up by 116.45% (from the last price of $2.31 to the average price target of $5), up by 116.45% based on the highest stock price target, and up by 116.45% based on the lowest stock price target.

Can Diversified Healthcare Trust stock reach $3?

DHC's average twelve months analyst stock price target of $5 supports the claim that Diversified Healthcare Trust can reach $3 in the near future.

What are Diversified Healthcare Trust's analysts' financial forecasts?

Diversified Healthcare Trust's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.55B (high $1.64B, low $1.47B), average EBITDA is $470.18M (high $495.73M, low $444.64M), average net income is $-220M (high $-205M, low $-236M), average SG&A $36.68M (high $38.68M, low $34.69M), and average EPS is $-0.92 (high $-0.855, low $-0.985). DHC's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $1.8B (high $1.9B, low $1.71B), average EBITDA is $546.19M (high $575.87M, low $516.52M), average net income is $0 (high $0, low $0), average SG&A $42.61M (high $44.93M, low $40.3M), and average EPS is $0 (high $0, low $0).

Did the DHC's actual financial results beat the analysts' financial forecasts?

Based on Diversified Healthcare Trust's last annual report (Dec 2023), the company's revenue was $1.41B, which missed the average analysts forecast of $1.42B by -0.35%. Apple's EBITDA was $-180M, missing the average prediction of $428.5M by -142.09%. The company's net income was $-272M, missing the average estimation of $1.09B by -124.90%. Apple's SG&A was $26.13M, missing the average forecast of $63.43M by -58.80%. Lastly, the company's EPS was $-1.14, beating the average prediction of $-0.91 by 25.27%. In terms of the last quarterly report (Dec 2023), Diversified Healthcare Trust's revenue was $1.51B, beating the average analysts' forecast of $360.99M by 319.24%. The company's EBITDA was $1.19B, beating the average prediction of $109.3M by 992.60%. Diversified Healthcare Trust's net income was $-103M, beating the average estimation of $-59.917M by 71.18%. The company's SG&A was $0, missing the average forecast of $8.53M by -100.00%. Lastly, the company's EPS was $-0.43, beating the average prediction of $-0.25 by 72.00%